Conmed

Q2 FY2026 EarningsQ2 FY26 results beat consensus on both top and bottom lines, with revenue of $343.5M vs. $337.5M expected and adjusted EPS of $1.38 (including a $0.21 tariff benefit) vs. $1.11 consensus. While reported sales growth was a modest +0.3% YoY due to strategic GI exits, organic constant currency growth reached a solid 6.0%. Management raised full-year adjusted EPS guidance to $4.48–$4.60, well ahead of previous expectations, signaling confidence in core growth platforms like AirSeal and Buffalo Filter.